Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 3
A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2 - 17 Years With Moderately to Severely Active Ulcerative Colitis
This Phase III, randomized, double-blind, multicenter, induction and maintenance study will evaluate the safety and efficacy of Afimkibart (RO7790121) in pedia…
Moderately to Severely Active Ulcerative Colitis
Estimated
~$10 – $7,500
Hoffmann-La RocheNCT07158242
Phase 3
A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Ulcerative Colitis
This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) comp…
Moderately to Severely Active Ulcerative Colitis
Estimated
~$10 – $7,500
Hoffmann-La RocheNCT06588855
Phase 1
A Randomized, Open-label, Pilot Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
The study is to evaluate the safety, feasibility, and preliminary efficacy of frozen FMT delivery via retention enema compared to lyophilized powder given in o…
Active Ulcerative Colitis (UC)
Estimated
~$10 – $6,250
The University of Texas Health Science Center, HoustonNCT05786404